Interaction databaseSupplement × PrescriptionReviewed May 2026

St. John's Wort and Suvorexant, a caution.

Suvorexant exposure is sensitive to CYP3A modulation, and St. John's Wort can induce CYP3A4. Combining them may lower suvorexant levels and reduce sleep benefit; stopping St. John's Wort can then restore exposure and increase next-day sleepiness. The effect depends on the hyperforin content of the St. John's Wort product.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
St. John's Wort and Suvorexant
Pair type
Caution
Evidence (highest tier)
Emerging
Source citations
2 sources
Stack Score effect
−5 to your Stack Score (per scored caution row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Caution · Emerging evidence

Caution

What is happening. Suvorexant exposure is sensitive to CYP3A modulation, and St. John's Wort can induce CYP3A4. Combining them may lower suvorexant levels and reduce sleep benefit; stopping St. John's Wort can then restore exposure and increase next-day sleepiness. The effect depends on the hyperforin content of the St. John's Wort product.

Mechanism. St. John's Wort induces CYP3A4 via hyperforin-mediated pregnane X receptor activation. Suvorexant is primarily metabolized by CYP3A, so induction can reduce systemic exposure and hypnotic effect.

Recommendation. Avoid St. John's Wort while using suvorexant unless your prescriber approves. Do not raise suvorexant to overcome reduced effect from the herb. If St. John's Wort is stopped, monitor for stronger sedation and next-day impairment.

Sources (2)
  1. Rhyne DN, Anderson SL. Suvorexant in insomnia: efficacy, safety and place in therapy. Ther Adv Drug Saf. 2015;6(5):189-195. PMID 26478806
  2. Nicolussi S, Drewe J, Butterweck V, Meyer zu Schwabedissen HE. Clinical relevance of St. John's wort drug interactions revisited. Br J Pharmacol. 2020;177(6):1212-1226. PMID 31742659

Stack Score

How this pair moves the number.

Effect on the composite score

If both St. John's Wort and Suvorexant are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.